Exploring the Mechanism of Action of Xuebijing Injection in Treating Acute Respiratory Distress Syndrome Based on Network Pharmacology and Animal Experiments

Jin Li,1,* Meirong Shen,2,* Zuan Yin3 1Department of Intensive Care Unit, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang City, Jiangxi Province, 330006, People’s Republic of China; 2Department of Intensive Care Unit, Ganzhou People’s Hospital, Gan...

Full description

Saved in:
Bibliographic Details
Main Authors: Li J, Shen M, Yin Z
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/exploring-the-mechanism-of-action-of-xuebijing-injection-in-treating-a-peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849312141593542656
author Li J
Shen M
Yin Z
author_facet Li J
Shen M
Yin Z
author_sort Li J
collection DOAJ
description Jin Li,1,* Meirong Shen,2,* Zuan Yin3 1Department of Intensive Care Unit, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang City, Jiangxi Province, 330006, People’s Republic of China; 2Department of Intensive Care Unit, Ganzhou People’s Hospital, Ganzhou City, Jiangxi Province, 341000, People’s Republic of China; 3Department of Emergency, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang City, Jiangxi Province, 330006, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zuan Yin, Department of Emergency, Jiangxi Provincial People’s Hospital, 152 Aiguo Road, Donghu District, Nanchang City, Jiangxi Province, 330006, People’s Republic of China, Email yuzan201709@126.comObjective: To explore the mechanism of Xuebijing injection (XBJ) in treating acute respiratory distress syndrome (ARDS) using network pharmacology and animal experiments.Methods: Active ingredients of XBJ were analyzed via TCMSP, and ARDS-related targets were identified through DisGENET and Genecard. Intersection targets were obtained using PubChem and Venn diagrams. Protein interaction networks, GO, and KEGG enrichment analyses were conducted. An ARDS rat model was established using lipopolysaccharide (LPS), and rats were divided into control, LPS, and XBJ-treated groups (low, medium, high doses, n=10). Lung wet/dry (W/D) ratio, inflammatory cytokines (IL-17, IL-6, IL-1β, TNF-α), MPO levels, lung pathology, and protein expression of ICAM-1 and HIF-1α were assessed via ELISA, HE staining, immunohistochemistry, and Western blot.Results: A total of 204 ARDS targets were identified, with 46 intersection targets, mainly TNF-α, MPO, HIF-1α, and ICAM-1. XBJ affected ARDS through IL-17, HIF-1, and TNF signaling pathways. In vivo, LPS-induced lung injury showed alveolar destruction, edema, and inflammation, with increased W/D ratio, cytokines, MPO, and protein expression of HIF-1α and ICAM-1 (P< 0.05). XBJ treatment alleviated lung damage, reduced inflammation, and improved pathology in a dose-dependent manner (P< 0.05).Conclusion: XBJ alleviates ARDS by regulating immune function, oxidative stress, and inflammation through IL-17, HIF-1, and TNF pathways.Keywords: network pharmacology, Xuebijing injection, acute respiratory distress syndrome, lipopolysaccharide
format Article
id doaj-art-ebf9ad5a86854e2a90639c5074accf67
institution Kabale University
issn 1178-7031
language English
publishDate 2025-05-01
publisher Dove Medical Press
record_format Article
series Journal of Inflammation Research
spelling doaj-art-ebf9ad5a86854e2a90639c5074accf672025-08-20T03:53:11ZengDove Medical PressJournal of Inflammation Research1178-70312025-05-01Volume 18Issue 160376047102764Exploring the Mechanism of Action of Xuebijing Injection in Treating Acute Respiratory Distress Syndrome Based on Network Pharmacology and Animal ExperimentsLi J0Shen M1Yin Z2Intensive care unitIntensive care unitDepartment of EmergencyJin Li,1,* Meirong Shen,2,* Zuan Yin3 1Department of Intensive Care Unit, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang City, Jiangxi Province, 330006, People’s Republic of China; 2Department of Intensive Care Unit, Ganzhou People’s Hospital, Ganzhou City, Jiangxi Province, 341000, People’s Republic of China; 3Department of Emergency, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang City, Jiangxi Province, 330006, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zuan Yin, Department of Emergency, Jiangxi Provincial People’s Hospital, 152 Aiguo Road, Donghu District, Nanchang City, Jiangxi Province, 330006, People’s Republic of China, Email yuzan201709@126.comObjective: To explore the mechanism of Xuebijing injection (XBJ) in treating acute respiratory distress syndrome (ARDS) using network pharmacology and animal experiments.Methods: Active ingredients of XBJ were analyzed via TCMSP, and ARDS-related targets were identified through DisGENET and Genecard. Intersection targets were obtained using PubChem and Venn diagrams. Protein interaction networks, GO, and KEGG enrichment analyses were conducted. An ARDS rat model was established using lipopolysaccharide (LPS), and rats were divided into control, LPS, and XBJ-treated groups (low, medium, high doses, n=10). Lung wet/dry (W/D) ratio, inflammatory cytokines (IL-17, IL-6, IL-1β, TNF-α), MPO levels, lung pathology, and protein expression of ICAM-1 and HIF-1α were assessed via ELISA, HE staining, immunohistochemistry, and Western blot.Results: A total of 204 ARDS targets were identified, with 46 intersection targets, mainly TNF-α, MPO, HIF-1α, and ICAM-1. XBJ affected ARDS through IL-17, HIF-1, and TNF signaling pathways. In vivo, LPS-induced lung injury showed alveolar destruction, edema, and inflammation, with increased W/D ratio, cytokines, MPO, and protein expression of HIF-1α and ICAM-1 (P< 0.05). XBJ treatment alleviated lung damage, reduced inflammation, and improved pathology in a dose-dependent manner (P< 0.05).Conclusion: XBJ alleviates ARDS by regulating immune function, oxidative stress, and inflammation through IL-17, HIF-1, and TNF pathways.Keywords: network pharmacology, Xuebijing injection, acute respiratory distress syndrome, lipopolysaccharidehttps://www.dovepress.com/exploring-the-mechanism-of-action-of-xuebijing-injection-in-treating-a-peer-reviewed-fulltext-article-JIRNetwork pharmacologyXuebijing injectionAcute respiratory distress syndromeLipopolysaccharide
spellingShingle Li J
Shen M
Yin Z
Exploring the Mechanism of Action of Xuebijing Injection in Treating Acute Respiratory Distress Syndrome Based on Network Pharmacology and Animal Experiments
Journal of Inflammation Research
Network pharmacology
Xuebijing injection
Acute respiratory distress syndrome
Lipopolysaccharide
title Exploring the Mechanism of Action of Xuebijing Injection in Treating Acute Respiratory Distress Syndrome Based on Network Pharmacology and Animal Experiments
title_full Exploring the Mechanism of Action of Xuebijing Injection in Treating Acute Respiratory Distress Syndrome Based on Network Pharmacology and Animal Experiments
title_fullStr Exploring the Mechanism of Action of Xuebijing Injection in Treating Acute Respiratory Distress Syndrome Based on Network Pharmacology and Animal Experiments
title_full_unstemmed Exploring the Mechanism of Action of Xuebijing Injection in Treating Acute Respiratory Distress Syndrome Based on Network Pharmacology and Animal Experiments
title_short Exploring the Mechanism of Action of Xuebijing Injection in Treating Acute Respiratory Distress Syndrome Based on Network Pharmacology and Animal Experiments
title_sort exploring the mechanism of action of xuebijing injection in treating acute respiratory distress syndrome based on network pharmacology and animal experiments
topic Network pharmacology
Xuebijing injection
Acute respiratory distress syndrome
Lipopolysaccharide
url https://www.dovepress.com/exploring-the-mechanism-of-action-of-xuebijing-injection-in-treating-a-peer-reviewed-fulltext-article-JIR
work_keys_str_mv AT lij exploringthemechanismofactionofxuebijinginjectionintreatingacuterespiratorydistresssyndromebasedonnetworkpharmacologyandanimalexperiments
AT shenm exploringthemechanismofactionofxuebijinginjectionintreatingacuterespiratorydistresssyndromebasedonnetworkpharmacologyandanimalexperiments
AT yinz exploringthemechanismofactionofxuebijinginjectionintreatingacuterespiratorydistresssyndromebasedonnetworkpharmacologyandanimalexperiments